RedHill Biopharma präsentiert positive Phase-2-Studiendaten mit oral verabreichtem Opaganib zur Behandlung von COVID-19 ...Middle East

Präsentation positiver Sicherheits- und Wirksamkeitsdaten der US-amerikanischen Phase-2-Studie mit Opaganib, ein führender neuartiger, oraler, dualer Wirkstoffkandidaten für die Behandlung von mittelschwerer bis schwerer COVID-19, auf dem World Microbe Forum Opaganib steht in Verbindung...

Hence then, the article about redhill biopharma prasentiert positive phase 2 studiendaten mit oral verabreichtem opaganib zur behandlung von covid 19 was published today ( Wednesday 23/06/2021 - 01:15 PM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RedHill Biopharma präsentiert positive Phase-2-Studiendaten mit oral verabreichtem Opaganib zur Behandlung von COVID-19 )

Also on site :

• Ernest James Lattimer arrested for multiple sex crimes involving children who were attending an in-home childcare facility on Emerald Way
• 4 found fatally shot inside Rancho Cordova home including 2 children
• Dunkin' Brings Back Highly Coveted Seasonal Flavor That Fans 'Really Needed Right Now'